Global Oral Proteins and Peptides Market Growth 2023-2029

Global Oral Proteins and Peptides Market Growth 2023-2029

Polypeptide and protein drugs refer to the biological drugs of polypeptide and protein substances used for prevention,treatment and diagnosis.Polypeptide is a compound formed by linking α-amino acids together with a peptide chain,and it is also an intermediate product of proteolysis.N polypeptide chains are entangled in a certain spatial structure to form a protein.The hydrolysis of macromolecular proteins produces polypeptides.Such drugs are biochemical preparations and have relatively strict requirements on storage and transportation environment.The Oral Proteins and Peptides industry can be broken down into several segments, Linaclotide, Insulin, Plecanatide, Cyclosporine, Octreotide, etc.Across the world, the major players cover Ironwood & Allergan (AbbVie), Novo Nordisk, Synergy Pharmaceuticals (Salix), Novartis, Chiasma (Amryt Pharma), etc.

LPI (LP Information)' newest research report, the “Oral Proteins and Peptides Industry Forecast” looks at past sales and reviews total world Oral Proteins and Peptides sales in 2022, providing a comprehensive analysis by region and market sector of projected Oral Proteins and Peptides sales for 2023 through 2029. With Oral Proteins and Peptides sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Proteins and Peptides industry.

This Insight Report provides a comprehensive analysis of the global Oral Proteins and Peptides landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Proteins and Peptides portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Oral Proteins and Peptides market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Proteins and Peptides and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Proteins and Peptides.

The global Oral Proteins and Peptides market size is projected to grow from US$ 2449 million in 2022 to US$ 6769.8 million in 2029; it is expected to grow at a CAGR of 6769.8 from 2023 to 2029.

Ironwood & Allergan is one of the most important global manufacturers of oral proteins and peptides, other key manufacturers include Novo Nordisk. North America is the largest market, occupied for over 60%. In terms of type, insulin is the largest segment, with a share of over 60%. And in terms of application, gastric & digestive disorders and bone diseases segment holds the most share.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Proteins and Peptides market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Linaclotide
Insulin
Plecanatide
Cyclosporine
Octreotide

Segmentation by application
Gastric & Digestive Disorders
Bone Diseases
Diabetes
Hormonal Disorders

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Ironwood & Allergan
Novo Nordisk
Synergy Pharmaceuticals （Salix）
Novartis
Chiasma (Amryt Pharma)

Key Questions Addressed in this Report

What is the 10-year outlook for the global Oral Proteins and Peptides market?

What factors are driving Oral Proteins and Peptides market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Oral Proteins and Peptides market opportunities vary by end market size?

How does Oral Proteins and Peptides break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.